Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	placenta development	NCOA6 PPARD PPARG ARID1A PTK2 CITED2 SERPINE1 HSD17B2	1.07e-05	197	110	8	GO:0001890
GeneOntologyCellularComponent	beta-catenin-TCF complex	BCL9L TCF4 TLE1	3.80e-05	13	109	3	GO:1990907
HumanPheno	Sandal gap	ATR EBF3 ARID1A MEIS2 ARID1B MBD5 PCNT	5.30e-06	96	38	7	HP:0001852
MousePheno	abnormal spongiotrophoblast size	NCOA6 ARID1A ELAVL1 HSD17B2	2.67e-05	28	88	4	MP:0012097
MousePheno	abnormal telencephalon morphology	TCF4 NCOA6 ATR EBF3 KATNB1 PPARD GFAP SLC17A5 ARID1B HSD17B2 DNAH5 ATP2B2 PLXNA2 SEC23A PRNP PCNT	4.08e-05	812	88	16	MP:0000787
MousePheno	abnormal forebrain morphology	TCF4 NCOA6 ATR EBF3 KATNB1 PPARD ARID1A GFAP SLC17A5 ARID1B HSD17B2 MBD5 DNAH5 ATP2B2 PLXNA2 SEC23A PRNP PCNT	1.02e-04	1072	88	18	MP:0000783
MousePheno	abnormal chorionic plate morphology	BCL9L PPARG ELAVL1	1.04e-04	15	88	3	MP:0004560
MousePheno	abnormal prenatal growth/weight/body size	CDK17 BCL9L SAMD1 NCOA6 SLC39A2 KATNB1 SPPL3 ELOVL1 PPARD PPARG ARID1A PTK2 MEIS2 CITED2 PTOV1 MRM3 ZDHHC15 EIF4G2 ELAVL1 HSD17B2 SEC23A PCNT	1.06e-04	1493	88	22	MP:0004196
MousePheno	abnormal embryonic growth/weight/body size	CDK17 BCL9L NCOA6 SLC39A2 KATNB1 SPPL3 PPARD PPARG ARID1A PTK2 MEIS2 CITED2 PTOV1 MRM3 ZDHHC15 EIF4G2 ELAVL1 HSD17B2 SEC23A PCNT	1.25e-04	1295	88	20	MP:0002088
MousePheno	abnormal gonadal fat pad morphology	PPARD PPARG AQP7P3 SLC30A5 MBD5	1.46e-04	80	88	5	MP:0005335
Domain	BAF250_C	ARID1A ARID1B	3.31e-05	2	108	2	IPR033388
Domain	BAF250_C	ARID1A ARID1B	3.31e-05	2	108	2	PF12031
Domain	BAF250/Osa	ARID1A ARID1B	3.31e-05	2	108	2	IPR021906
Domain	1Cnucl_rcpt	PPARD PPARG	9.90e-05	3	108	2	IPR003074
Domain	DUF2075	SLFN13 SLFN11	9.90e-05	3	108	2	IPR018647
Domain	DUF2075	SLFN13 SLFN11	9.90e-05	3	108	2	PF09848
Domain	IPT	EBF3 PKHD1L1 PLXNA2	4.97e-04	27	108	3	SM00429
Domain	AlbA_2	SLFN13 SLFN11	6.83e-04	7	108	2	PF04326
Domain	Schlafen	SLFN13 SLFN11	6.83e-04	7	108	2	IPR029684
Domain	Schlafen_AAA_dom	SLFN13 SLFN11	6.83e-04	7	108	2	IPR007421
Domain	TIG	EBF3 PKHD1L1 PLXNA2	7.51e-04	31	108	3	PF01833
Domain	IPT	EBF3 PKHD1L1 PLXNA2	8.25e-04	32	108	3	IPR002909
Domain	NA_SOLUT_SYMP_1	SLC5A12 SLC5A8	1.76e-03	11	108	2	PS00456
Domain	NA_SOLUT_SYMP_2	SLC5A12 SLC5A8	2.11e-03	12	108	2	PS00457
Domain	SSF	SLC5A12 SLC5A8	2.11e-03	12	108	2	PF00474
Domain	Na/solute_symporter	SLC5A12 SLC5A8	2.11e-03	12	108	2	IPR001734
Domain	NA_SOLUT_SYMP_3	SLC5A12 SLC5A8	2.11e-03	12	108	2	PS50283
Domain	HEAT	ATR SF3B1 SYMPK	2.69e-03	48	108	3	PF02985
Domain	-	ARID1A ARID1B	3.31e-03	15	108	2	1.10.150.60
Domain	BRIGHT	ARID1A ARID1B	3.31e-03	15	108	2	SM00501
Domain	ARID_dom	ARID1A ARID1B	3.31e-03	15	108	2	IPR001606
Domain	ARID	ARID1A ARID1B	3.31e-03	15	108	2	PS51011
Domain	ARID	ARID1A ARID1B	3.31e-03	15	108	2	PF01388
Domain	ARM-type_fold	ATR ARID1A ARFGEF3 SF3B1 EIF4G2 PPP6R2 SYMPK	3.56e-03	339	108	7	IPR016024
Domain	HEAT	ATR SF3B1 SYMPK	4.61e-03	58	108	3	IPR000357
Domain	ARM-like	ATR ARID1A ARID1B SF3B1 PPP6R2 SYMPK	4.84e-03	270	108	6	IPR011989
Pathway	WP_KLEEFSTRA_SYNDROME	NCOA6 ARID1A ARID1B MBD5	2.26e-05	29	82	4	M48076
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	ATR WDR33 SRP54 ARID1A PRPF40A SF3B1 ELAVL1 MAP2K2 HNRNPLL CNOT1 SEC23A PCNT SYMPK	5.29e-08	582	112	13	20467437
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	CPEB2 BCL9L NCOA6 WDR33 LSG1 ARID1A PRPF40A ARID1B TLE1 CNOT1 CNOT2	2.85e-07	457	112	11	32344865
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	POTEKP CREB5 PTK2 SF3B1 POTEJ MAP2K2 ATP2B2 CNOT1	3.20e-07	202	112	8	24639526
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CDSN EBF3 WDR33 LSG1 SRP54 ARID1A PRPF40A ARID1B SF3B1 MRPS11 ELAVL1 HNRNPLL CNOT1 TNXB SYMPK	2.11e-06	1082	112	15	38697112
Pubmed	Human Ccr4-Not complex is a ligand-dependent repressor of nuclear receptor-mediated transcription.	PPARG CNOT1 CNOT2	3.84e-06	10	112	3	16778766
Pubmed	Targeting a complex transcriptome: the construction of the mouse full-length cDNA encyclopedia.	TCF4 CDSN XIRP1 ELOVL1 SCARA5 PAFAH2 ELAVL1 SEC23A	5.01e-06	292	112	8	12819125
Pubmed	Arid1a regulates bladder urothelium formation and maintenance.	PPARG ARID1A ARID1B	7.00e-06	12	112	3	35283102
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	ESD ARID1A PRPF40A ARID1B SF3B1 ELAVL1 SYMPK	7.60e-06	220	112	7	35785414
Pubmed	Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-δ gene.	PPARD PPARG	1.03e-05	2	112	2	24486511
Pubmed	The function of the nuclear receptor peroxisome proliferator-activated receptor delta in energy homeostasis.	PPARD PPARG	1.03e-05	2	112	2	14677574
Pubmed	Pleiotropic effects of peroxisome proliferator-activated receptor γ and δ in vascular diseases.	PPARD PPARG	1.03e-05	2	112	2	24107399
Pubmed	The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.	PPARD PPARG	1.03e-05	2	112	2	32198386
Pubmed	The function of peroxisome proliferator-activated receptors PPAR-γ and PPAR-δ in Mycobacterium leprae-induced foam cell formation in host macrophages.	PPARD PPARG	1.03e-05	2	112	2	33075048
Pubmed	Association of peroxisome proliferator-activated receptor α/δ/γ with obesity, and gene-gene interaction, in the Chinese Han population.	PPARD PPARG	1.03e-05	2	112	2	23545576
Pubmed	+294T/C polymorphism in the PPAR-delta gene is associated with risk of coronary artery disease in normolipidemic Tunisians.	PPARD PPARG	1.03e-05	2	112	2	20645257
Pubmed	PPARδ deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis.	PPARD PPARG	1.03e-05	2	112	2	21192919
Pubmed	Peroxisome proliferator-activated receptor-γ activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1.	PPARG SERPINE1	1.03e-05	2	112	2	23461356
Pubmed	Endothelial, but not smooth muscle, peroxisome proliferator-activated receptor β/δ regulates vascular permeability and anaphylaxis.	PPARD PPARG	1.03e-05	2	112	2	25556996
Pubmed	Influence of tumor peroxisome proliferator-activated receptor gamma and delta expression on postoperative mortality of patients undergoing colorectal cancer surgery.	PPARD PPARG	1.03e-05	2	112	2	19283612
Pubmed	Cinnamaldehyde Contributes to Insulin Sensitivity by Activating PPARδ, PPARγ, and RXR.	PPARD PPARG	1.03e-05	2	112	2	26227398
Pubmed	Impact of peroxisome proliferator-activated receptors gamma and delta on adiposity in toddlers and preschoolers in the GENESIS Study.	PPARD PPARG	1.03e-05	2	112	2	18379566
Pubmed	PPARβ/δ activation protects against hepatic ischaemia-reperfusion injury.	PPARD PPARG	1.03e-05	2	112	2	37833850
Pubmed	Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.	PPARG SERPINE1	1.03e-05	2	112	2	14747283
Pubmed	PPARγ activation induces acute PAI-1 gene expression in the liver but not in adipose tissues of diabetic model mice.	PPARG SERPINE1	1.03e-05	2	112	2	21757225
Pubmed	Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis.	ARID1A ARID1B	1.03e-05	2	112	2	37611161
Pubmed	Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.	ARID1A ARID1B	1.03e-05	2	112	2	32791957
Pubmed	Peroxisome proliferator-activated receptor-γ and -δ polymorphisms in women with polycystic ovary syndrome.	PPARD PPARG	1.03e-05	2	112	2	20840271
Pubmed	Comparison of PPARδ and PPARγ in inhibiting the pro-inflammatory effects of C-reactive protein in endothelial cells.	PPARD PPARG	1.03e-05	2	112	2	19395102
Pubmed	PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.	PPARD PPARG	1.03e-05	2	112	2	12740443
Pubmed	Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.	ARID1A ARID1B	1.03e-05	2	112	2	28967863
Pubmed	PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation.	PPARD PPARG	1.03e-05	2	112	2	15247146
Pubmed	Activation of PPARδ in bone marrow endothelial progenitor cells improves their hematopoiesis-supporting ability after myelosuppressive injury.	PPARD PPARG	1.03e-05	2	112	2	38704134
Pubmed	The effects of kefir, koumiss, yogurt and commercial probiotic formulations on PPARα and PPAR-β/δ expressions in mouse kidney.	PPARD PPARG	1.03e-05	2	112	2	24205877
Pubmed	Expression of the sodium-coupled monocarboxylate transporters SMCT1 (SLC5A8) and SMCT2 (SLC5A12) in retina.	SLC5A12 SLC5A8	1.03e-05	2	112	2	17591909
Pubmed	Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.	PPARD PPARG	1.03e-05	2	112	2	23374874
Pubmed	Dual ARID1A/ARID1B loss leads to rapid carcinogenesis and disruptive redistribution of BAF complexes.	ARID1A ARID1B	1.03e-05	2	112	2	34386776
Pubmed	Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.	ARID1A ARID1B	1.03e-05	2	112	2	23202128
Pubmed	Genomic organization of the mouse peroxisome proliferator-activated receptor beta/delta gene: alternative promoter usage and splicing yield transcripts exhibiting differential translational efficiency.	PPARD PPARG	1.03e-05	2	112	2	12059785
Pubmed	CITED2 signals through peroxisome proliferator-activated receptor-gamma to regulate death of cortical neurons after DNA damage.	PPARG CITED2	1.03e-05	2	112	2	18495890
Pubmed	ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics.	ARID1A ARID1B	1.03e-05	2	112	2	33890484
Pubmed	Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation.	PPARD PPARG	1.03e-05	2	112	2	22021335
Pubmed	Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice.	PPARD PPARG	1.03e-05	2	112	2	17641685
Pubmed	ARID1B is a specific vulnerability in ARID1A-mutant cancers.	ARID1A ARID1B	1.03e-05	2	112	2	24562383
Pubmed	Genetic polymorphisms of peroxisome proliferator-activated receptors and the risk of cardiovascular morbidity and mortality in a community-based cohort in washington county, Maryland.	PPARD PPARG	1.03e-05	2	112	2	18288282
Pubmed	Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation.	PPARD PPARG	1.03e-05	2	112	2	17713572
Pubmed	The contrasting roles of PPARδ and PPARγ in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue.	PPARD PPARG	1.03e-05	2	112	2	21843327
Pubmed	Pro12Ala PPAR-γ2 and +294T/C PPAR-δ Polymorphisms and Association with Metabolic Traits in Teenagers from Northern Mexico.	PPARD PPARG	1.03e-05	2	112	2	32664384
Pubmed	Activation of PPARγ and δ by dietary punicic acid ameliorates intestinal inflammation in mice.	PPARD PPARG	1.03e-05	2	112	2	21736821
Pubmed	The effect of neuronal conditional knock-out of peroxisome proliferator-activated receptors in the MPTP mouse model of Parkinson's disease.	PPARD PPARG	1.03e-05	2	112	2	26028469
Pubmed	PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.	PPARD PPARG	1.03e-05	2	112	2	21070867
Pubmed	Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in kidney.	SLC5A12 SLC5A8	1.03e-05	2	112	2	17692818
Pubmed	A de novo deafwaddler mutation of Pmca2 arising in ES cells and hitchhiking with a targeted modification of the Pparg gene.	PPARG ATP2B2	1.03e-05	2	112	2	16845470
Pubmed	ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.	ARID1A ARID1B	1.03e-05	2	112	2	29890703
Pubmed	Differential expression, distribution, and function of PPAR-gamma in the proximal and distal colon.	PPARG GFAP	1.03e-05	2	112	2	17519361
Pubmed	SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.	ARID1A ARID1B	1.03e-05	2	112	2	24788099
Pubmed	Mouse Slfn8 and Slfn9 genes complement human cells lacking SLFN11 during the replication stress response.	SLFN13 SLFN11	1.03e-05	2	112	2	37833372
Pubmed	Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.	ARID1A ARID1B	1.03e-05	2	112	2	33052929
Pubmed	Peroxisome proliferator-activated receptor gamma mediated inhibition of plasminogen activator inhibitor type 1 production and proliferation of human umbilical vein endothelial cells.	PPARG SERPINE1	1.03e-05	2	112	2	14581151
Pubmed	Nuclear receptors of the peroxisome proliferator-activated receptor (PPAR) family in gestational diabetes: from animal models to clinical trials.	PPARD PPARG	1.03e-05	2	112	2	20427759
Pubmed	Gene-gene interaction between PPARδ and PPARγ is associated with abdominal obesity in a Chinese population.	PPARD PPARG	1.03e-05	2	112	2	23273766
Pubmed	CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.	PPARG CITED2	1.03e-05	2	112	2	23212831
Pubmed	Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.	ARID1A ARID1B	1.03e-05	2	112	2	27562491
Pubmed	Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.	PPARD PPARG	1.03e-05	2	112	2	20221637
Pubmed	Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-δ/β overexpression.	PPARD PPARG	1.03e-05	2	112	2	24681603
Pubmed	Activation of PPARbeta/delta inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release.	PPARD PPARG	1.03e-05	2	112	2	19389799
Pubmed	Structure of Schlafen13 reveals a new class of tRNA/rRNA- targeting RNase engaged in translational control.	SLFN13 SLFN11	1.03e-05	2	112	2	29563550
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	CPEB2 LIN28B WDR33 RPS13 PRPF40A MRM3 SF3B1 EIF4G2 MRPS11 ELAVL1 HNRNPLL CNOT1	1.19e-05	807	112	12	22681889
Pubmed	A comprehensive analysis of 22q11 gene expression in the developing and adult brain.	GFAP GGT2P GGT3P TBX5	1.37e-05	45	112	4	14614146
Pubmed	Human transcription factor protein interaction networks.	BCL9L TCF4 NCOA6 WDR33 RPS13 PPARG ARID1A PRPF40A ZEB2 ARID1B TLE1 MRPS11 ELAVL1 CNOT1 CNOT2 SYMPK	1.40e-05	1429	112	16	35140242
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CPEB2 CDK17 RPS13 GRIN2A ARID1A PRPF40A GFAP SF3B1 EIF4G2 ELAVL1 LRRC7 PPP6R2 ATP2B2 CNOT1 SEC23A PRNP	1.43e-05	1431	112	16	37142655
Pubmed	Identification of candidate genes at the corticoseptal boundary during development.	TCF4 GFAP ZEB2	1.44e-05	15	112	3	16458080
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	BCL9L RPS13 GRIN2A GFAP ARFGEF3 SF3B1 ACSBG1 EIF4G2 LRRC7 PPP6R2 HNRNPLL CNOT1 CNOT2 PRNP	1.83e-05	1139	112	14	36417873
Pubmed	Identification of a polymorphic, neuron-specific chromatin remodeling complex.	ARID1A GFAP ARID1B	2.14e-05	17	112	3	12368262
Pubmed	Adipocyte arrestin domain-containing 3 protein (Arrdc3) regulates uncoupling protein 1 (Ucp1) expression in white adipose independently of canonical changes in β-adrenergic receptor signaling.	NCOA6 PPARD PPARG	2.14e-05	17	112	3	28291835
Pubmed	Early embryonic lethality of mice with disrupted transcription cofactor PIMT/NCOA6IP/Tgs1 gene.	NCOA6 PPARD PPARG	3.03e-05	19	112	3	22982455
Pubmed	Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.	PPARD PPARG	3.08e-05	3	112	2	9113987
Pubmed	Peroxisome Proliferator Activated Receptor Gamma Controls Mature Brown Adipocyte Inducibility through Glycerol Kinase.	PPARD PPARG	3.08e-05	3	112	2	29346772
Pubmed	TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression.	TCF4 ZEB2	3.08e-05	3	112	2	31933004
Pubmed	Changes in plasma PPARs levels in migraine patients.	PPARD PPARG	3.08e-05	3	112	2	25758678
Pubmed	Genetics of patent ductus arteriosus susceptibility and treatment.	ZEB2 TBX5	3.08e-05	3	112	2	22414880
Pubmed	Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle.	ARID1A ARID1B	3.08e-05	3	112	2	21647563
Pubmed	Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma.	EBF3 SLC5A8	3.08e-05	3	112	2	18559491
Pubmed	Association and interaction of PPARα, δ, and γ gene polymorphisms with low-density lipoprotein-cholesterol in a Chinese Han population.	PPARD PPARG	3.08e-05	3	112	2	26098621
Pubmed	Roles of PPARs on regulating myocardial energy and lipid homeostasis.	PPARD PPARG	3.08e-05	3	112	2	17356846
Pubmed	Structure and assembly of the NOT module of the human CCR4-NOT complex.	CNOT1 CNOT2	3.08e-05	3	112	2	24121232
Pubmed	Polymorphisms in PPARD, PPARG and APM1 associated with four types of traditional Chinese medicine constitutions.	PPARD PPARG	3.08e-05	3	112	2	20621019
Pubmed	HuR-induced circ_0082319 contributes to hepatocellular carcinoma by elevating PTK2 through miR-505-3p.	PTK2 ELAVL1	3.08e-05	3	112	2	37878047
Pubmed	Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction.	PPARD PPARG	3.08e-05	3	112	2	27179975
Pubmed	[Effects of PPARD-87T > C and interactions with single nucleotide polymorphisms in PPARA and PPARG on abdominal obesity].	PPARD PPARG	3.08e-05	3	112	2	22944052
Pubmed	Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study.	PPARD PPARG	3.08e-05	3	112	2	15128052
Pubmed	DISC1 regulates astrogenesis in the embryonic brain via modulation of RAS/MEK/ERK signaling through RASSF7.	GFAP ACSBG1	3.08e-05	3	112	2	27287808
Pubmed	Cnot1, Cnot2, and Cnot3 maintain mouse and human ESC identity and inhibit extraembryonic differentiation.	CNOT1 CNOT2	3.08e-05	3	112	2	22367759
Pubmed	Peroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells.	PPARD PPARG	3.08e-05	3	112	2	21765467
Pubmed	PPARα deficiency augments a ketogenic diet-induced circadian PAI-1 expression possibly through PPARγ activation in the liver.	PPARG SERPINE1	3.08e-05	3	112	2	20854792
Pubmed	The Role of Peroxisome Proliferator-Activated Receptors and Their Transcriptional Coactivators Gene Variations in Human Trainability: A Systematic Review.	PPARD PPARG	3.08e-05	3	112	2	29762540
Pubmed	Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity.	PPARD PPARG	3.08e-05	3	112	2	18657264
Pubmed	Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptor-gamma/delta-mediated effect that links lipid metabolism and immunity.	PPARD PPARG	3.08e-05	3	112	2	18323470
Pubmed	Effects of PPARs/20-HETE on the renal impairment under diabetic conditions.	PPARD PPARG	3.08e-05	3	112	2	31163124
Pubmed	Aciculin interacts with filamin C and Xin and is essential for myofibril assembly, remodeling and maintenance.	XIRP1 PGM5	3.08e-05	3	112	2	24963132
Pubmed	PPAR and GST polymorphisms may predict changes in intellectual functioning in medulloblastoma survivors.	PPARD PPARG	3.08e-05	3	112	2	30607709
Interaction	KLF4 interactions	RPS13 PPARG ARID1A ZEB2 ARID1B TLE1 MRPS11 PRNP	2.73e-06	160	110	8	int:KLF4
Interaction	NUP35 interactions	CPEB2 BCL9L NCOA6 WDR33 ARID1A PRPF40A ARID1B TLE1 SLFN11 CNOT1 CNOT2 TBX5	3.53e-06	424	110	12	int:NUP35
GeneFamily	Solute carriers	SLC39A2 SLC22A11 RHAG SLC17A5 SLC30A5 SLC5A12 SLC5A8 SLC22A20P	1.71e-04	395	72	8	752
GeneFamily	Schlafen family	SLFN13 SLFN11	3.24e-04	7	72	2	1110
GeneFamily	CCR4-NOT transcription complex	CNOT1 CNOT2	8.40e-04	11	72	2	1023
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTEKP POTEJ	1.19e-03	13	72	2	685
GeneFamily	CD molecules\|Gamma-glutamyltransferases	GGT2P GGT3P	1.19e-03	13	72	2	564
GeneFamily	AT-rich interaction domain containing	ARID1A ARID1B	1.59e-03	15	72	2	418
GeneFamily	WD repeat domain containing	WDR33 KATNB1 WDR97 WDR87 TLE1	3.91e-03	262	72	5	362
Coexpression	GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP	TCF4 SH3RF1 SQLE ELOVL1 APOBR CUEDC2 SCARA5 PAFAH2 PPP6R2	1.89e-07	200	111	9	M3979
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 TCF4 EBF3 MEIS2 ITIH5 TNXB PLXNA2	6.15e-07	194	112	7	a429d22c8c9d0fd3bfa9f877a6364cecad68db30
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6\|TCGA-Liver / Sample_Type by Project: Shred V9	TCF4 IGFN1 SLC39A2 ZEB2 SCARA5 TNXB	4.42e-06	169	112	6	e992530776cab922d0360b275fb9cb8bd0017b06
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TCF4 GRIN2A MEIS2 PGM5 CITED2 QRFPR	4.58e-06	170	112	6	7fa022471e14ac8a3bc147c793368a4d56a8e591
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 EBF3 PKHD1L1 PGM5 TNXB PLXNA2	5.40e-06	175	112	6	9a96a946db731ba24c9be34bedebf1f4a1372b9e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 EBF3 PKHD1L1 PGM5 TNXB PLXNA2	5.40e-06	175	112	6	54c1f080195ad8392a095e83b56a4b54073d4c0d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 EBF3 PKHD1L1 PGM5 TNXB PLXNA2	5.40e-06	175	112	6	2b51406a2c2daa13ab4ed283ede038cd11d9e641
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 PKHD1L1 ARFGEF3 FREM2 DNAH5 OTOG	7.20e-06	184	112	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGFN1 GRIN2A ZEB2 MEIS2 LRRC7 TNXB	7.20e-06	184	112	6	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 PKHD1L1 ARFGEF3 FREM2 DNAH5 OTOG	7.20e-06	184	112	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 PKHD1L1 ARFGEF3 FREM2 DNAH5 OTOG	7.20e-06	184	112	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TCF4 EBF3 CREB5 SCARA5 SERPINE1 TNXB	7.43e-06	185	112	6	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 TCF4 PPARG CREB5 MEIS2 PLXNA2	8.14e-06	188	112	6	c2c51c6526defe2600302901159b8abbb58d7595
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 EBF3 PPARG MEIS2 ITIH5 PLXNA2	8.39e-06	189	112	6	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	CDK17 TCF4 PKHD1L1 TLE1 SERPINE1 PLXNA2	8.39e-06	189	112	6	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	PTK2 TLE1 SERPINE1 MBD5 PPP6R2 PLXNA2	8.65e-06	190	112	6	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	S1PR2 ITIH5 SCARA5 LOXL3 TNXB PRNP	9.46e-06	193	112	6	92048d2e9e43513e6185e09553be3ee47d7e5207
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	S1PR2 ITIH5 SCARA5 LOXL3 TNXB PRNP	9.46e-06	193	112	6	ac088c8f27b5b1888610e461ff45870ca60da886
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 TCF4 PPARG MEIS2 ITIH5 PLXNA2	1.00e-05	195	112	6	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Scara5+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CREB5 MEIS2 PGM5 ITIH5 SCARA5 TNXB	1.00e-05	195	112	6	d663d54a4bcc94e2c9b50ed931e2b2db4ca41373
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 TCF4 EBF3 MEIS2 ITIH5 PLXNA2	1.00e-05	195	112	6	d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GRIN2A ZEB2 MEIS2 SERPINE1 HSD17B2 TNXB	1.03e-05	196	112	6	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	COVID-19_Severe-Classical_Monocyte-cMono_3\|COVID-19_Severe / Disease condition and Cell class	FPR1 RPS13 ZEB2 CREB5 CITED2 PRNP	1.13e-05	199	112	6	ffb2ef9b7006cbed0f43637af040719b9776cbd5
ToppCell	COVID-19-kidney-EC(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	TCF4 CDSN ZEB2 MEIS2 SLFN11	2.89e-05	141	112	5	fd08f4add62af55d2114afcf681c3c6b995e8e57
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Neurod2\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CDSN QRFPR SLC5A12 SLC5A8	3.86e-05	75	112	4	3bc5df14f21c1c93c2a0fd5fc47bc5d146ba87a2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LIN28B EBF3 GRIN2A ZEB2 MEIS2	3.88e-05	150	112	5	1270f33f9d7e46e55adf1a96e8beee858b95589d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LIN28B EBF3 GRIN2A ZEB2 MEIS2	3.88e-05	150	112	5	156118ce1d69522624196410cba18b8354cd0bb4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 BCL9L TCF4 PPARG MEIS2	4.40e-05	154	112	5	e51a5114f0ec38f997f5b8bbf3a7770f98595474
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CCDC51 SERPINE1 LOXL3 TNXB SYMPK	4.82e-05	157	112	5	f086753b51860e23f1275bd75e8802d2a7d7b70a
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RFX8 SLC5A12 SLC22A20P TNXB OTOG	4.82e-05	157	112	5	7fdc0094dd5729990a91a30c1982a14c74650b52
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RFX8 SLC5A12 SLC22A20P TNXB OTOG	4.82e-05	157	112	5	c762b03e254c73222094725ca8ac1c8eb428bccb
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RFX8 SLC5A12 SLC22A20P TNXB OTOG	4.82e-05	157	112	5	6b5b08bb5520fcf6f4c0560f7ed7645ec179806d
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRIN2A FREM2 DNAH5 ATP2B2 PLXNA2	4.97e-05	158	112	5	f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRIN2A FREM2 DNAH5 ATP2B2 PLXNA2	4.97e-05	158	112	5	8c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	S1PR2 APOBR ITIH5 SCARA5 TNXB	5.12e-05	159	112	5	cb2470b288c13e454a2a80115b0d5613b3f718e6
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LIN28B PKHD1L1 FREM2 LRRC7 HEPHL1	5.59e-05	162	112	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated\|E18.5-samps / Age Group, Lineage, Cell class and subclass	FPR1 PPARG APOBR CREB5 ALDH3B1	5.59e-05	162	112	5	60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed
ToppCell	E18.5-samps-Myeloid\|E18.5-samps / Age Group, Lineage, Cell class and subclass	FPR1 PPARG APOBR CREB5 ALDH3B1	5.59e-05	162	112	5	18e4a807e25f754a69e9eaaddfde40f8de9b8512
ToppCell	droplet-Marrow-BM-30m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF4 RHAG ABCB4 MRM3 PRNP	5.59e-05	162	112	5	75df7ff779a3b9159ba97d852da1f8df650b9ce5
ToppCell	E18.5-samps-Myeloid-Macrophage\|E18.5-samps / Age Group, Lineage, Cell class and subclass	FPR1 PPARG APOBR CREB5 ALDH3B1	5.59e-05	162	112	5	0970e4eda60e3f015335e2726e6d565fb2f43372
ToppCell	PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCF4 PKHD1L1 MEIS2 NIM1K TNXB	6.10e-05	165	112	5	347b59aa625a8a960828b8620824d8ac48990e07
ToppCell	PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCF4 PKHD1L1 MEIS2 NIM1K TNXB	6.10e-05	165	112	5	507c89ece0a336b8e9c65b79889a714e17ddca27
ToppCell	PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCF4 PKHD1L1 MEIS2 NIM1K TNXB	6.10e-05	165	112	5	39a25be081a5d59c7cf107a997d352793d5025fb
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 TCF4 MEIS2 ATP2B2 PLXNA2	6.10e-05	165	112	5	a74751e0ec857aa974bec04ccc747c004a8f6e01
ToppCell	PND03-Endothelial-Endothelial_lymphatic\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TCF4 PKHD1L1 MEIS2 NIM1K TNXB	6.10e-05	165	112	5	1890f9c33b0c5b381d57f97042da2610a093a6de
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EBF3 PPARG MEIS2 ITIH5 PLXNA2	6.28e-05	166	112	5	8e2faca6a2e76a625de04d6098aa6f98911945c6
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FPR1 MEIS2 OVGP1 LRRC7 TBX5	6.65e-05	168	112	5	b87fc63f9e35dfcfc46cb129ea569e73c5e018bb
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FPR1 MEIS2 OVGP1 LRRC7 TBX5	6.65e-05	168	112	5	b96a48552f4236a95bbcdce2f1b05041086d7101
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CDSN MEIS2 HEPHL1 ATP2B2 PLXNA2	6.83e-05	169	112	5	c7fc3a8c44f07c557b60d469717b66e2f5863d38
ToppCell	URO-Lymphocyte-B-B_intermediate\|URO / Disease, Lineage and Cell Type	TCF4 PKHD1L1 MEIS2 ABCB4 TLE1	7.03e-05	170	112	5	e11d1510518cedabeece96d4adbb90999e6326fa
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122\|Adult / Lineage, Cell type, age group and donor	PKHD1L1 MEIS2 PGM5 TLE1 TNXB	7.63e-05	173	112	5	dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCell	TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3\|TCGA-Breast / Sample_Type by Project: Shred V9	EBF3 PPARG ITIH5 SCARA5 TNXB	7.84e-05	174	112	5	7f8f5fafae08676d2b90cab9802c3c9320f1370e
ToppCell	TCGA-Breast-Solid_Tissue_Normal\|TCGA-Breast / Sample_Type by Project: Shred V9	EBF3 PPARG ITIH5 SCARA5 TNXB	7.84e-05	174	112	5	e2f240d60bffbe8e6d60f0bb405b231bd3c96875
ToppCell	TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue\|TCGA-Breast / Sample_Type by Project: Shred V9	EBF3 PPARG ITIH5 SCARA5 TNXB	7.84e-05	174	112	5	0f3ec0d0d4344e10c9b48adc9174123f6402dc51
ToppCell	(03)_Secretory-(0)_uninjured\|(03)_Secretory / shred by cell type and Timepoint	SQLE CITED2 ARFGEF3 SLC5A8 ALDH3B1	7.84e-05	174	112	5	ebdddb5091afcc49ab533c890f260f709880c5f9
ToppCell	TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue\|TCGA-Breast / Sample_Type by Project: Shred V9	EBF3 PPARG ITIH5 SCARA5 TNXB	7.84e-05	174	112	5	1aadbf2642b6d1320ceabd92e6ff59e11f16c315
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	S1PR2 PPARG SLC17A5 TNXB CNOT2	8.06e-05	175	112	5	16849ea8f0985108baa2085f34c3de14a4f9f28b
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	TCF4 PKHD1L1 CREB5 PGM5 TNXB	8.28e-05	176	112	5	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	TCF4 PKHD1L1 CREB5 PGM5 TNXB	8.28e-05	176	112	5	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GFAP ZEB2 ITIH5 ACSBG1 PRNP	8.28e-05	176	112	5	792f414f5092aba14260b8e16378e793a822498e
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5\|TCGA-Skin / Sample_Type by Project: Shred V9	TCF4 RFX8 ITIH5 FREM2 LOXL3	8.73e-05	178	112	5	ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14
ToppCell	COVID-19-kidney-PCT-S1/S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SLC22A11 GGT2P FREM2 SLC5A12 SLC5A8	8.73e-05	178	112	5	23a12d3d971b857d5be8e907334d1f6b49eeeb32
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SH3RF1 PGM5 ITIH5 LRRC7 TNXB	9.20e-05	180	112	5	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	SH3RF1 PTK2 ARFGEF3 FREM2 DNAH5	9.44e-05	181	112	5	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC39A2 FPR1 PPARG CREB5 IL17RA	9.69e-05	182	112	5	3dec003bad0f3716cf8163861a9d4302a7d6df8c
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TCF4 PKHD1L1 CREB5 PGM5 TNXB	9.94e-05	183	112	5	4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCell	droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC39A2 FPR1 PPARG CREB5 SERPINE1	9.94e-05	183	112	5	ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f
ToppCell	droplet-Lung-nan-3m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC39A2 FPR1 PPARG CREB5 SERPINE1	1.02e-04	184	112	5	3261d767d5e3d9e9fbac22ad73ca14e44beed89c
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CDK17 TCF4 MEIS2 SERPINE1 CNOT2	1.05e-04	185	112	5	673308ca0514a4d3629d61fe91e9d8fb31b72166
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FPR1 APOBR ZEB2 CREB5 IL17RA	1.07e-04	186	112	5	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	TCF4 PKHD1L1 PTK2 MEIS2 SERPINE1	1.10e-04	187	112	5	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	normal_Lung-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	CPEB2 TCF4 ABCB4 ARID1B SCARA5	1.10e-04	187	112	5	a3592f056e1c2f82ba325fea2ecc4dd6c6347c81
ToppCell	facs-Bladder-nan-24m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEIS2 ITIH5 SCARA5 TNXB PRNP	1.10e-04	187	112	5	2c145e9d11424939dd99012a8cedf5d998b966e9
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PKHD1L1 PGM5 ZDHHC15 OVGP1 PAFAH2	1.13e-04	188	112	5	dc52dd2957be3f40001f0a56f3d9ac9d66ea466e
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PKHD1L1 PGM5 ZDHHC15 OVGP1 PAFAH2	1.13e-04	188	112	5	2ef08313087e91985bcffc46c3798470cdeec49c
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PKHD1L1 PGM5 ZDHHC15 OVGP1 PAFAH2	1.13e-04	188	112	5	1f1604b6dc0a8ad0be3d9aac0bef448459c22465
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PKHD1L1 CREB5 PGM5 TLE1 TNXB	1.13e-04	188	112	5	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	facs-BAT-Fat-18m-Mesenchymal\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	S1PR2 ITIH5 SCARA5 LOXL3 TNXB	1.16e-04	189	112	5	bba28f57a0708515fdd5acd9592dbbe4a4f57116
ToppCell	facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	S1PR2 ITIH5 SCARA5 LOXL3 TNXB	1.16e-04	189	112	5	cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2
ToppCell	10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	EBF3 CREB5 ITIH5 SCARA5 TNXB	1.16e-04	189	112	5	473b01c9162b12b90a617c600238436177a0d18d
ToppCell	droplet-Tongue-Unstain-18m-Epithelial-keratinocyte\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDSN ESD RPS13 ELOVL1 HEPHL1	1.16e-04	189	112	5	7ee9b00a8bd46f2da9218623bb2617b2e585f9d5
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	CDK17 TCF4 PKHD1L1 SERPINE1 PLXNA2	1.16e-04	189	112	5	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	control-Myeloid-CD14_Monocytes_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SQLE RPS13 ZEB2 SLFN11 PRNP	1.16e-04	189	112	5	7f78b5bb8195f99b18082cbb612e9199b7a1538c
ToppCell	facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	S1PR2 ITIH5 SCARA5 LOXL3 TNXB	1.16e-04	189	112	5	87323e86a5b5d159920a07e6bd7ef5e3438cd085
ToppCell	droplet-Marrow-nan-3m-Hematologic-erythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 GFAP RHAG ABCB4 PRNP	1.16e-04	189	112	5	8a38baee58a27c2fa3f4bd131ab9f15723ed9295
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 PKHD1L1 RHAG PGM5 TNXB	1.19e-04	190	112	5	876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	TCF4 PTK2 MEIS2 SERPINE1 PLXNA2	1.19e-04	190	112	5	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TCF4 PKHD1L1 CREB5 PGM5 TNXB	1.19e-04	190	112	5	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 MEIS2 PGM5 CITED2 TLE1	1.19e-04	190	112	5	6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2
ToppCell	(4)_Endothelial_cells-(40)_EC-arterial\|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	EBF3 PGM5 ITIH5 SERPINE1 PRNP	1.19e-04	190	112	5	ff774faf3f12759d11e50ed7d189288bb79e22e1
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	TCF4 PGM5 ITIH5 SLFN13 MBD5	1.19e-04	190	112	5	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 PKHD1L1 RHAG PGM5 TNXB	1.19e-04	190	112	5	be9f36127028f52ca5fc1b32ba15a6c26aad69ac
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 PKHD1L1 RHAG PGM5 TNXB	1.19e-04	190	112	5	09a8855901c3c9332dbaab3e40166485b696d0f1
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	TCF4 PTK2 MEIS2 SERPINE1 PLXNA2	1.19e-04	190	112	5	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 MEIS2 PGM5 QRFPR TNXB	1.22e-04	191	112	5	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 TCF4 MEIS2 SERPINE1 PLXNA2	1.22e-04	191	112	5	b2c86cde341fe350143658c8a8a4a9edbce3f19b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IGFN1 EBF3 MEIS2 SCARA5 TNXB	1.22e-04	191	112	5	2c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZEB2 CREB5 ITIH5 SCARA5 TNXB	1.22e-04	191	112	5	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	droplet-Marrow-BM-1m-Hematologic-erythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1L1 GFAP RHAG ABCB4 PRNP	1.22e-04	191	112	5	d78d4fbb0b8317dbf14e32182466a432abef3e93
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CREB5 ITIH5 SCARA5 TNXB PRNP	1.25e-04	192	112	5	0e7e55505bd5454d7cf952a63fdcb46ec76f1973
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	CDK17 PPARD CREB5 SERPINE1 PLXNA2	1.25e-04	192	112	5	8b86db2ebe0199fee0e9800566a619a24bfdeed5
Disease	colon cancer (is_implicated_in)	NCOA6 ATR PPARG ARID1A	9.47e-06	36	109	4	DOID:219 (is_implicated_in)
Disease	Stomach Neoplasms	ATR PPARG ARID1A PTOV1 SERPINE1 MRPS11 PRNP SYMPK	1.51e-05	297	109	8	C0038356
Disease	Malignant neoplasm of stomach	ATR PPARG ARID1A PTOV1 SERPINE1 MRPS11 PRNP SYMPK	1.62e-05	300	109	8	C0024623
Disease	Seckel syndrome 1	ATR PCNT	4.05e-05	3	109	2	C4551474
Disease	non-Hodgkin lymphoma (implicated_via_orthology)	ATR S1PR2	4.05e-05	3	109	2	DOID:0060060 (implicated_via_orthology)
Disease	Hereditary Diffuse Gastric Cancer	PPARG ARID1A PTOV1 SERPINE1 MRPS11 PRNP SYMPK	1.11e-04	293	109	7	C1708349
Disease	Malignant Neoplasms	ATR LIN28B ARID1A CITED2 SF3B1	1.16e-04	128	109	5	C0006826
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1A ARID1B	1.34e-04	5	109	2	C3281201
Disease	proliferative diabetic retinopathy (is_implicated_in)	PPARG SERPINE1	2.01e-04	6	109	2	DOID:13207 (is_implicated_in)
Disease	adrenoleukodystrophy (implicated_via_orthology)	ELOVL1 ACSBG1	2.81e-04	7	109	2	DOID:10588 (implicated_via_orthology)
Disease	aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology)	GGT2P GGT3P	2.81e-04	7	109	2	DOID:5022 (biomarker_via_orthology)
Disease	alcohol dependence (biomarker_via_orthology)	GGT2P GGT3P	3.73e-04	8	109	2	DOID:0050741 (biomarker_via_orthology)
Disease	Primary sclerosing cholangitis	TCF4 ABCB4	3.73e-04	8	109	2	C0566602
Disease	Disease Exacerbation	ZEB2 ABCB4 PTOV1 MRPS11 SYMPK	3.76e-04	165	109	5	C0235874
Disease	nasopharynx carcinoma (is_marker_for)	ATR GRIN2A ARID1A	5.43e-04	43	109	3	DOID:9261 (is_marker_for)
Disease	tenascin measurement	SCARA5 TNXB	5.97e-04	10	109	2	EFO_0008296
Disease	neuroblastoma (is_implicated_in)	ARID1A ARID1B	5.97e-04	10	109	2	DOID:769 (is_implicated_in)
Disease	Neuroblastoma	LIN28B ARID1A ARID1B	7.06e-04	47	109	3	C0027819
Disease	glomerulosclerosis (implicated_via_orthology)	PPARG SERPINE1	7.28e-04	11	109	2	DOID:0050851 (implicated_via_orthology)
Disease	Coffin-Siris syndrome	ARID1A ARID1B	1.03e-03	13	109	2	C0265338
Disease	Graves ophthalmopathy (is_marker_for)	PPARG SERPINE1	1.03e-03	13	109	2	DOID:0081120 (is_marker_for)
Disease	Peripheral Nervous System Diseases	TCF4 PPARD GFAP	1.06e-03	54	109	3	C4721453
Disease	Pneumoconiosis	ATR OVGP1	1.20e-03	14	109	2	C0032273
Disease	Bagassosis	ATR OVGP1	1.20e-03	14	109	2	C0004681
Disease	tetralogy of Fallot (implicated_via_orthology)	CITED2 DNAH5	1.20e-03	14	109	2	DOID:6419 (implicated_via_orthology)
Disease	chenodeoxycholate measurement	FPR1 SLC22A20P	1.38e-03	15	109	2	EFO_0010471
Disease	Situs ambiguus	BCL9L DNAH5	1.38e-03	15	109	2	C0266642
Disease	autism spectrum disorder, schizophrenia	TCF4 GRIN2A SF3B1 ATP2B2 CNOT1 TNXB	1.38e-03	327	109	6	EFO_0003756, MONDO_0005090
Disease	T-Cell Lymphoma	PPARG ARID1A	1.57e-03	16	109	2	C0079772
Disease	hypertension (biomarker_via_orthology)	PPARG PTK2 ARID1B EIF4G2 SERPINE1	1.57e-03	227	109	5	DOID:10763 (biomarker_via_orthology)
Disease	syndrome (implicated_via_orthology)	ZDHHC15 CNOT1	1.99e-03	18	109	2	DOID:225 (implicated_via_orthology)
Disease	ischemia (biomarker_via_orthology)	PTK2 ARID1B	1.99e-03	18	109	2	DOID:326 (biomarker_via_orthology)
Disease	Bipolar Disorder	TCF4 GRIN2A PPARD GFAP MBD5 MPPE1 PCNT	2.00e-03	477	109	7	C0005586
Disease	Chronic myeloproliferative disorder	ATR PCNT	2.22e-03	19	109	2	C1292778
Disease	melanoma	GRIN2A PPARD PPARG SLC17A5 MAP2K2	2.31e-03	248	109	5	C0025202
Disease	Endometrial Carcinoma	ATR ARID1A HSD17B2	2.43e-03	72	109	3	C0476089
Disease	Paroxysmal atrial fibrillation	CREB5 PTK2 MBD5 TBX5	2.72e-03	156	109	4	C0235480
Disease	familial atrial fibrillation	CREB5 PTK2 MBD5 TBX5	2.72e-03	156	109	4	C3468561
Disease	Persistent atrial fibrillation	CREB5 PTK2 MBD5 TBX5	2.72e-03	156	109	4	C2585653
Disease	Seckel syndrome	ATR PCNT	2.98e-03	22	109	2	C0265202
Disease	Atrial Fibrillation	CREB5 PTK2 MBD5 TBX5	2.98e-03	160	109	4	C0004238
Disease	Epilepsy, Cryptogenic	GRIN2A GFAP ARID1B	3.51e-03	82	109	3	C0086237
Disease	irritability measurement	TCF4 NCOA6 PRNP	3.51e-03	82	109	3	EFO_0009594
Disease	Awakening Epilepsy	GRIN2A GFAP ARID1B	3.51e-03	82	109	3	C0751111
Disease	Aura	GRIN2A GFAP ARID1B	3.51e-03	82	109	3	C0236018

Protein segments in the cluster

Peptide	Gene	Start	Entry
TFGPRMHMNDGRVVS	UXS1	261	Q8NBZ7
QRMSIFGHSMGGHGA	ESD	141	P10768
TAQPNTMLGRMFGSG	BTBD10	186	Q9BSF8
TMLGRMFGSGREHNF	BTBD10	191	Q9BSF8
FPSIVGRPRHQGMME	POTEKP	31	Q9BYX7
GGTTMYPGIAHRMQK	POTEKP	301	Q9BYX7
GFMHMTLASLPFGGV	ALDH3B1	391	P43353
QGLGHMQTGVGMSLA	CCNJ	326	Q5T5M9
PGFAHIPRGTIGDMM	CUEDC2	66	Q9H467
ASTPHGQMTPMQGGR	ARID1B	1286	Q8NFD5
MGSSRAPWMGRVGGH	CDSN	1	Q15517
PMLLSGTHVMEGSGR	ATP2B2	256	Q01814
SGHGMDSRPAMAIFE	MAP2K2	306	P36507
FSPAQRHGNSGITMM	QRFPR	356	Q96P65
YMHGGNPSGSVVMVS	HNRNPLL	326	Q8WVV9
PGLIHALGGMANANM	HACL1	86	Q9UJ83
MGVRGFGRSMPTSMA	PGM5	331	Q15124
GTLPPGRMSHASMGN	ARID1A	851	O14497
GRMSHASMGNRPYGP	ARID1A	856	O14497
MHNAVGGAMTGPGTH	CREB5	101	Q02930
DGMDNRTVGGSMRHP	FBXO42	516	Q6P3S6
GLMNAHSMGIGVGLF	GGT3P	76	A6NGU5
MFQPGRMHRVGELSG	IL17RA	541	Q96F46
ALSGARMGQGMGAIH	LOXL3	356	P58215
MRGFMTAHGQPDQPR	LSG1	516	Q9H089
HPFDTGMTLGQGMSR	ITIH5	926	Q86UX2
LGMLPYGGISAMHAG	LRRC7	1296	Q96NW7
HMLVGSNMPIFGGGR	EDRF1	316	Q3B7T1
TAHPDTMLGRMFGPG	KCTD20	136	Q7Z5Y7
MGSFVLDGQQHMGIR	MEIS2	366	O14770
FGVTMGVHMAGRTSG	AQP7P3	76	A6NL99
GDMHGIIGPSHNGAM	TCF4	416	P15884
TFHVLLSMPMGGRIG	FREM2	1976	Q5SZK8
LTAGKMMSEFPGHTG	KATNB1	176	Q9BVA0
MMSEFPGHTGPVNVV	KATNB1	181	Q9BVA0
MGFGFISMINREGSP	LIN28B	41	Q6ZN17
MAMIELGFGRQNFHP	MPPE1	1	Q53F39
KVMVHVGGMVFSPGS	PLXNA2	1211	O75051
FGHRGAPMLGPENTM	GDPD4	201	Q6W3E5
VIGGSLGSFMAMPRN	CDK17	76	Q00537
QRFRFSPMGVDHMSG	ELAVL1	216	Q15717
SSGEMMVGGLAPGRR	GFAP	16	P14136
MTAVYMNGGGLVNPH	NIM1K	1	Q8IY84
GGHIMPPTQSQFGEM	EIF4G2	411	P78344
GMFTVGDHPPEQRGM	PCNT	131	O95613
FMSLGTIMAIAHGSG	ABCB4	56	P21439
AHGSGLPLMMIVFGE	ABCB4	66	P21439
IMGNGFAGCMLFPHI	PTOV1	181	Q86YD1
MRPGTGAERGGLMVS	PRPF40A	1	O75400
GNSVRMEAGFPMASG	NCOA6	156	Q14686
GFAGAMAHTGSIMNL	OR8B12	151	Q8NGG6
VPFRLTHNMVNGMGP	ATR	2511	Q13535
RDHRRTGNMGIPGTM	CPEB2	146	Q7Z5Q1
MDQGQMRHSFSAGPE	ARFGEF3	2071	Q5TH69
NMRHPLTGGGMTVAF	SQLE	411	Q14534
QGVQRGLNMSMCHPG	BCL9L	1381	Q86UU0
MCHPGQMSLLGRTGV	BCL9L	1391	Q86UU0
GAAPMMAETQHFFLG	ACSBG1	451	Q96GR2
VKIAPGGMGSFHAMI	ELOVL1	156	Q9BW60
ATMPHLSRGMGQIYE	HEPHL1	701	Q6MZM0
SPVHMMGTGIGRIEA	MBD5	441	Q9P267
AQGPMGHFSQGLADM	IGFN1	451	Q86VF2
GNNPAHTGMMGVNSF	EBF3	426	Q9H4W6
LSMGAVFAIMGGFIH	MT-CO1	381	P00395
NVSSMGGGAPMERLA	HSD17B2	216	P37059
GILHTVGRLGAMMGP	SLC22A11	466	Q9NSA0
APGSGTRQVFSMAAM	SAMD1	396	Q6SPF0
RQMGMGFASVHARLG	SLC22A20P	456	A6NK97
EGLGEGVTFPAMHAM	SLC17A5	171	Q9NRA2
RGMHMPTSPTFLEGN	S1PR2	336	O95136
MMIRLVNGSGPHEGR	SCARA5	391	Q6ZMJ2
FVHGLPGSGKTIMAM	SLFN13	596	Q68D06
TQRVRHGMMTLGPSG	DNAH5	2251	Q8TE73
TQAAGGMRRGNMGHL	PPP6R2	466	O75170
GLMNAHSMGIGVGLF	GGT2P	76	P36268
VGTHPRMGNLGLQME	OVGP1	601	Q12889
DMSRVAVMGHSFGGA	PAFAH2	226	Q99487
RHNPTGTVLFMGQVM	SERPINE1	386	P05121
VTHGGMRVQLPHVMG	OTOG	226	Q6ZRI0
RMSFQLPGGMIITGF	SFXN2	91	Q96NB2
MDPRVLHHMGGMAGL	SRP54	466	P61011
LGMSHNAIRFGRMPE	PPARD	136	Q03181
GMANHGSPQLGEGMF	TBX5	441	Q99593
MMGRSPGFAMQHIVG	CCDC51	1	Q96ER9
GMGAHFRMPIINNLE	MRM3	256	Q9HC36
HLGTGMERSPGAMER	PTK2	21	Q05397
STLPFFMVRKAMGGH	FPR1	76	P21462
VGMSHNAIRFGRMPQ	PPARG	201	P37231
VLSGGTTMYPGMAHR	POTEJ	961	P0CG39
FVHGLPGSGKTIMAM	SLFN11	596	Q7Z7L1
QAALSVFGMVGGPLM	SLC5A8	411	Q8N695
NTGARIMMFIGGPAT	SEC23A	281	Q15436
ISAGVFLGAGFMHMT	SLC39A2	51	Q9NP94
MGPRPMAGSTDQIAH	SH3RF1	426	Q7Z6J0
FGLAHPGMMQELQAR	APOBR	1076	Q0VD83
MAMNHGRFPDGTNGL	CITED2	6	Q99967
GNMNATSGIRHAMGP	CITED2	61	Q99967
IDRAHGGPNFMMHSG	CNOT1	1821	A5YKK6
GGPNFMMHSGISQAS	CNOT1	1826	A5YKK6
YGQQSALGLPMRGMS	CNOT2	76	Q9NZN8
PGRLSAMHGLIMGGL	MRPS11	156	P82912
PFGMVPHAGMNGELT	TLE1	371	Q04724
TPLGGMTGFHMQTED	SF3B1	436	O75533
GSHFSMLGIGDIVMP	SPPL3	261	Q8TCT6
RMVFVGHTGPVTAMT	WDR97	326	A6NE52
MPTHMGQGRYPVGVS	RFX8	496	Q6ZV50
MGRMHAPGKGLSQSA	RPS13	1	P62277
NMYGLHDGQRMGPLS	TNXB	1541	P22105
GGYMLGSAMSRPIIH	PRNP	126	P04156
IHPFGSMIIGSIAGM	RHAG	291	Q02094
VMFHAPVPGANMVTG	PKHD1L1	2441	Q86WI1
RLMATQMTAAGLGPG	SYMPK	451	Q92797
RNGPVAMVGSAAMGG	TIMM17A	106	Q99595
AGGGMNANMRGVFLH	SLC30A5	581	Q8TAD4
HMGPMSERRHEQSGG	WDR33	966	Q9C0J8
MQHLGVGMEAPLLGF	ZEB2	436	O60315
SIHGMCGGPMLGLFS	SLC5A12	411	Q1EHB4
GGTGLQIAHMVSMPG	WDR87	141	Q6ZQQ6
LDPSMGMGHLRASGA	XIRP1	976	Q702N8
GSSPGDGHSFPMRSM	ZDHHC15	286	Q96MV8
FVPILGIHGGASMIM	GRIN2A	121	Q12879